Clinical trials show that nausea affects approximately 44% of patients taking semaglutide (Wegovy) and about 24-40% of those on tirzepatide (Zepbound), with rates varying by dose
Common signs that your fasting window may be too aggressive include shakiness, dizziness, unusual fatigue, headaches, constipation, irritability, trouble concentrating, or feeling overly full after only a few bites
Semaglutide, however, works by controlling appetite and helping people feel full faster, which can lead to weight loss
Decision board Is Sermorelin the right page to act on
Methods Adults ( 18 years old) with T2D required at least one prescription for injectable semaglutide at index date (treatment switch), at least one prescription for any other GLP-1 RA in the previous 365 days, a baseline HbA1c and/or weight measurement in the 90 days pre-index and a follow-up measurement at 180 and 365 days post-index
Whether immature thyroid tissue in young children responds differently to chronic GLP-1 receptor stimulation is unknown